AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Poolbeg Pharma Highlights POLB 001 Interest and Financial Discipline
September 18, 2024 06:24 PM AEST| By Team Kalkine MediaPoolbeg Pharma PLC,(LSE:POLB),has outlined significant advancements for its lead drug, POLB 001, in its recent first-half results report, which also noted a cash balance of £10.1 million as of June 30.,POLB 001 is being developed as the first approve...
Advanced Medical Solutions (LSE:AMS) Delivers Revenue Growth in Latest Half Driven by Surgical Business Surge
September 18, 2024 06:21 PM AEST| By Team Kalkine MediaAdvanced Medical Solutions Group plc (LSE:AMS), a global leader in tissue-healing technologies, has released its unaudited interim results for the six months ending 30 June 2024. The company reported an 8% increase in revenue, reaching £68.0 million,...
Synairgen Names Inhaled Drug Development Expert as Chairman
September 18, 2024 05:28 PM AEST| By Team Kalkine MediaSynairgen PLC,(LSE:SNG),has announced that chairman Simon Shaw will retire at the upcoming annual shareholder meeting, set for 10 October in London. He will be succeeded by Mark Parry-Billings, recognized as a leader in inhaled drug development.,Dr....
MaxRets Ventures Appoints Non-Executive Director
September 17, 2024 05:52 PM AEST| By Team Kalkine MediaMaxRets Ventures PLC,(LSE:MAX),has announced the appointment of Luca Zanni as a non-executive director. Zanni, aged 44, is recognized for his extensive experience in financial management across a variety of industries.,Zanni’s career includes a serie...
Panmure Says - Scancell Well-Positioned to Secure Funding
September 17, 2024 05:29 PM AEST| By Team Kalkine MediaBroker Panmure Liberum has reiterated its favorable rating on Scancell Holdings PLC (LSE:SCLP) shares, maintaining a target price of 23.3p in light of Scancell’s recent strategic partnership with PharmaJet. The collaboration is set to utilize PharmaJ...
Scancell Partners with ParmaJet for Needle-Free Cancer Vaccine Delivery
September 17, 2024 05:18 PM AEST| By Team Kalkine MediaScancell Holdings PLC,(LSE:SCLP),has entered into a strategic partnership with PharmaJet to provide the Stratis intramuscular (IM) needle-free injection system. This system will be utilized for administering Scancell’s SCIB1/iSCIB1+ DNA cancer vaccin...
Ananda Raises £2.2M Total, with Additional £80K from Retail Offer
September 16, 2024 06:04 PM AEST| By Team Kalkine MediaAnanda Developments Plc (AQSE: ANA) has announced the successful raising of £2.225 million through a combination of financing efforts. The total amount includes £79,996 acquired via a WRAP retail offer, supplementing the proceeds from a recent placin...
AstraZeneca Drops After Downgrade Following Cancer Drug Update
September 14, 2024 03:40 AM AEST| By Team Kalkine MediaAstraZeneca,(LSE:AZN),experienced a decline of £4 billion in its market value following a downgrade from Deutsche Bank, which has revised its recommendation for the company to 'sell' in light of the latest update on the lung cancer drug datopotamab.,...
Proteome Sciences Slips as Losses Mount and CEO Steps Down
September 14, 2024 03:32 AM AEST| By Team Kalkine MediaProteome Sciences PLC,(LSE:PRM),experienced a significant drop of over 17% in its share value on the back of a recent announcement detailing increased financial losses and the resignation of its chief executive, Mariola Soehngen.,Mariola Soehngen, wh...
GSK's Cancer Drugs Fast-Tracked for Approval in China
September 13, 2024 08:25 PM AEST| By Team Kalkine MediaGSK PLC,(LSE:GSK),has announced that its blood cancer medication, Blenrep (belantamab mafodotin), has been granted Breakthrough Therapy Designation (BTD) in China. This designation, awarded by the National Medical Products Administration (NMPA), is i...
Premier African to Announce Zulu Plant Restart Date Following Lab Tests
September 13, 2024 06:49 PM AEST| By Team Kalkine MediaPremier African Minerals Ltd,(LSE:PREM),has received an update from its flotation plant supplier, Enprotec, indicating that no major fundamental changes are required to bring the equipment to optimal performance. Enprotec has been conducting a series...
Futura Medical Consensus Significantly Increases
September 12, 2024 09:23 PM AEST| By Team Kalkine MediaAnalysts tracking Futura Medical PLC,(LSE:FUM),have revised and notably increased their revenue forecasts following the company's better-than-anticipated interim results. The sexual healthcare company achieved a maiden profit ahead of schedule, promp...
Haleon Announces Pricing for £1bn Bond Offering
September 12, 2024 08:26 PM AEST| By Team Kalkine MediaHaleon PLC,(LSE:HLN),has announced the pricing details for a significant bond offering, expected to raise nearly £1 billion through its subsidiary. The FTSE 100-listed health company revealed that €750 million worth of Euro medium-term notes will be...
GSK Achieves Success in mRNA Flu Vaccine Trial
September 12, 2024 07:50 PM AEST| By Team Kalkine MediaGSK PLC,(LSE:GSK),has reported promising results for its mRNA-based seasonal flu vaccine. The company has advanced this vaccine to phase III trials following positive outcomes in phase II testing. This comes on the heels of less favorable news regard...
_08_30_2024_15_24_26_992096.jpg)
Renishaw (LSE:RSW): Steady growth in analytical instruments and medical devices balances flat performance in manufacturing technologies
September 12, 2024 05:51 PM AEST| By Team Kalkine MediaRenishaw plc (LSE:RSW) has reported its financial results for the year ended 30 June 2024, delivering record revenue of £691.3 million, slightly up from £688.6 million in FY2023. The company’s revenue growth, though modest at 0.4%, was bolstered by a...
Celadon Pharmaceuticals Shares Fall 20% After Discounted Fundraiser
September 11, 2024 09:45 PM AEST| By Team Kalkine MediaShares of Celadon Pharmaceuticals PLC,(LSE: CEL),fell by 20% following the announcement of a £1.05 million equity fundraising round, which involved issuing new shares at a discounted rate.,The company, which specializes in cannabis-based medicines, h...
ANGLE Technology Establishes New Benchmark in Cancer Diagnostics
September 11, 2024 08:47 PM AEST| By Team Kalkine MediaANGLE PLC,(LSE:AGL),has received high praise from German investment bank Berenberg, which has reaffirmed its 'buy' recommendation and 70p price target for the company. Currently, ANGLE’s shares are trading at 11.28p.,Berenberg’s note highlights ANGLE...
Arecor Receives Positive Review, Price Target Maintained
September 11, 2024 08:40 PM AEST| By Team Kalkine MediaPanmure Liberum has reaffirmed its positive rating and ambitious price target for shares in Arecor Therapeutics PLC,(LSE:AREC),following the company’s announcement of data presentation from a Phase I trial of its fast-acting insulin, AT278, at a majo...
Futura Medical: Investment Bank Affirms Performance Matches Claims
September 11, 2024 08:34 PM AEST| By Team Kalkine Media"Doing what it says on the tube" was the headline from a Panmure Liberum report following Futura Medical PLC's,(LSE:FUM),interim results.,The report highlighted a significant achievement for Futura Medical, which has developed a fast-acting erectile...
Arecor Therapeutics Presents Promising Data at Madrid Conference
September 11, 2024 05:54 PM AEST| By Team Kalkine MediaArecor Therapeutics PLC,(LSE:AREC),will present positive Phase I trial results for its ultra-concentrated, ultra-rapid-acting insulin, AT278, at the European Association for the Study of Diabetes (EASD) 2024 conference in Madrid. The trial, which inc...
AI on the Rise: A Look at Top AI Companies and Their Stocks